Literature DB >> 9590367

Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.

D Ellis1, K Y Forrest, J Erbey, T J Orchard.   

Abstract

Urinary samples were concentrated rapidly and efficiently and were used to develop several protein assays that may be of value in monitoring individuals with progressive renal disorders. Transforming growth factor-beta1 (TGF-11) and retinol binding protein (RBP) were measured with modification of commercially available methods used to assay serum specimens; type 3 collagen (T3C) was measured with a new immunonephelometric assay. The precision characteristics of these assays are comparable with those reported for microalbuminuria. The clinical utility of measuring a panel of these markers was demonstrated in urine samples from 16 control subjects and from 46 individuals with insulin-dependent diabetes mellitus (IDDM) with various albumin excretion rates (AERs). TGF-beta1 and T3C were used as markers of cytokine expression and of the renal fibrogenic process, whereas RBP excretion served as a marker of tubular injury or dysfunction. Compared with controls, T3C excretion was significantly increased in 18 normoalbuminuric and further increased in 13 microalbuminuric (AER 20 < or = 200 microg/min) IDDM subjects. RBP excretion was increased in macroalbuminuric IDDM subjects (AER >200 microg/min, overt nephropathy). Significant correlations were also found between AER and RBP in all but macroalbuminuric individuals, whereas TGF-beta1 correlated with T3C excretion in controls and in normoalbuminuric diabetic subjects. Urinary RBP but not AER was an excellent predictor of diabetic nephropathy as defined by serum creatinine (P = 0.0001). This underscores the importance of an early tubulopathy in the subsequent development of glomerulopathy and overt nephropathy. The data suggest that longitudinal monitoring of a panel of urinary markers such as that used in the current study may better define their relevance in progressive glomerulosclerosis and may also provide greater insight into the mechanisms underlying such process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590367

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Association between Urine Ammonium and Urine TGF-β1 in CKD.

Authors:  Kalani L Raphael; Sarah Gilligan; Thomas H Hostetter; Tom Greene; Srinivasan Beddhu
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-16       Impact factor: 8.237

2.  Effect of calcium dobesilate on nephropathy in type 2 diabetic rats.

Authors:  Xiaocheng Liu; Xinming Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Age-related differences in adriamycin-induced nephropathy.

Authors:  Hyewon Hahn; Young Seo Park; Il Soo Ha; Hae Il Cheong; Yong Choi
Journal:  Pediatr Nephrol       Date:  2004-05-11       Impact factor: 3.714

4.  ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.

Authors:  Xiao-yan Zhang; Xiao-qiang Ding; Wen-Lv Lv; Jie Teng; Yi-Hong Zhong
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

5.  Determinants of intravascular resistance in Indian diabetic nephropathy patients: a hospital-based study.

Authors:  Anubhav Thukral; Manish Mishra; Vaibhava Srivastava; Hemant Kumar; Amit Nandan Dhar Dwivedi; Ram Chandra Shukla; Kamlakar Tripathi
Journal:  Int J Vasc Med       Date:  2011-06-12

6.  Urinary sodium excretion has positive correlation with activation of urinary renin angiotensin system and reactive oxygen species in hypertensive chronic kidney disease.

Authors:  Shin-Young Ahn; Sejoong Kim; Dong Ki Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim; Suhnggwon Kim; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2014-09-30       Impact factor: 2.153

7.  Urinary active transforming growth factor β in feline chronic kidney disease.

Authors:  J S Lawson; H M Syme; C P D Wheeler-Jones; J Elliott
Journal:  Vet J       Date:  2016-02-12       Impact factor: 2.688

8.  Haptoglobin genotype and renal function decline in type 1 diabetes.

Authors:  Tina Costacou; Robert E Ferrell; Demetrius Ellis; Trevor J Orchard
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

9.  Protocol of an observational study to evaluate diabetic nephropathy through detection of microalbuminuria in Indian patients.

Authors:  Manisha Sahay; Sanjay Kalra; Vijay Vishwanathan; Abdul Hamid Zargar; Pradeep G Talwalkar; Subhash Kuamr Wangnoo; Debasish Maji; G Vijay Kumar; Ramesh Kumar Sharma; Deodatta Chafekar; Brij Mohan; Ganapathi Bantwal; Anil Bansali; Jasmeet Singh Sahni
Journal:  Indian J Endocrinol Metab       Date:  2013-05

Review 10.  Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Authors:  Camelia R Ban; Stephen M Twigg
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.